Anupam Rasayan India Limited has submitted newspaper advertisement clippings to stock exchanges following the publication of its postal ballot notice and remote e-voting intimation. The company filed the compliance documentation on April 08, 2026, with BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI Listing Regulations.

Newspaper Publication Compliance

The company published advertisements in today's edition of two newspapers to ensure wider shareholder awareness:

Company Secretary & Compliance Officer Ashish Gupta confirmed that copies of the newspaper advertisements will also be hosted on the company's official website for easy access by stakeholders.

Postal Ballot Resolutions

The newspaper advertisements detail two critical resolutions requiring shareholder approval through remote electronic voting:

These resolutions focus on securing the USD 20,000,000 credit facility availed by Doriath S.à.r.l., a wholly-owned subsidiary, from Altis XII Pte. Ltd. for the acquisition of Jayhawk Fine Chemicals Corporation completed on February 27, 2026.

Remote E-Voting Timeline

The published advertisements confirm the comprehensive voting schedule established by the company:

The company has engaged National Securities Depository Limited (NSDL) to provide the e-voting facility, with M/s. M.D. Baid & Associates serving as scrutinizer for the postal ballot process.

Shareholder Communication Strategy

The postal ballot notice has been distributed exclusively through electronic mode to shareholders whose email addresses are registered with the company or depositories, in compliance with MCA circulars. The advertisements emphasize that voting rights will be determined based on equity shares held as on the cut-off date of April 03, 2026.

The resolutions are designed to ensure continuity of financing arrangements and maintain security interest integrity for the USD 20,000,000 credit facility. Upon consolidation, both Doriath and Jayhawk are expected to be considered material subsidiaries under SEBI regulations.

Anupam Rasayan India Limited has received positive news from CRISIL Ratings, which has removed the company from 'Rating Watch with Negative Implications' and reaffirmed its credit ratings following successful acquisition funding and improved operational performance.

Rating Action Details

CRISIL Ratings has reaffirmed the company's credit ratings across its bank loan facilities worth Rs 1369.82 crore. The rating action reflects the completion of funding arrangements for the company's strategic acquisition and demonstrated improvements in working capital management.

Acquisition Funding Success

The ratings were initially placed on 'Watch Negative' following the company's announcement to acquire 100% equity in Jayhawk Fine Chemicals LLC, a US-based specialty chemicals company, for $150 million. The resolution of the watch status was driven by the successful completion of funding arrangements.

The company structured the acquisition funding through a balanced approach:

• Debt component: $41 million raised through debt financing
• Equity component: $109 million of Class B non-voting equity infused by Altix XII Pte Ltd, a fund managed by Oaktree Capital Management LLP

Operational Performance Improvements

The company demonstrated significant operational improvements during the first nine months of fiscal 2026. Revenue performance showed substantial growth, reaching Rs 1,729 crore compared to Rs 938 crore in the corresponding period of the previous fiscal year.

This revenue improvement contributed to better working capital management:

Business Strengths and Market Position

CRISIL highlighted the company's strong business risk profile, backed by its established market position in custom synthesis and manufacturing of specialty chemicals. With nearly four decades of experience, the group serves 75 clients globally, including 31 multinational companies across agrochemicals, personal care, pharmaceuticals, and specialty segments.

The rating agency noted the company's diversified revenue streams, with pharmaceutical and polymer segments expected to contribute more than 30% of total revenue in fiscal 2026. The acquisition of Tanfac Industries provides backward integration benefits, securing supply of critical raw materials like hydrogen fluoride and potassium fluoride.

Financial Risk Profile

The company maintains a strong financial risk profile with healthy capital structure metrics. As of September 30, 2025, the networth stood at Rs 3,197.3 crore with a total outside liabilities to adjusted networth ratio of 0.6 times, compared to Rs 2,935.6 crore and 0.74 times as of March 31, 2025.

Outlook and Future Prospects

CRISIL assigned a 'Stable' outlook to the long-term rating, expecting the group's operating performance to continue benefiting from its established brand and comfortable financial risk profile. The rating agency anticipates further improvement in the working capital cycle with the commercialization of new products and expects the company to maintain its market position through expansion into high-value fluorination chemistry products and polymer applications.